Pellagra in Zanzibar: a rare diagnosis.
Journal
International journal of dermatology
ISSN: 1365-4632
Titre abrégé: Int J Dermatol
Pays: England
ID NLM: 0243704
Informations de publication
Date de publication:
May 2023
May 2023
Historique:
revised:
05
11
2022
received:
21
08
2022
accepted:
18
11
2022
medline:
19
4
2023
pubmed:
3
12
2022
entrez:
2
12
2022
Statut:
ppublish
Résumé
Pellagra is a nutritional disease resulting from a deficiency of vitamin B3 (niacin) primarily due to corn consumption, especially in developing countries, but in developed countries, it can occur secondarily as a consequence of chronic alcoholism, malabsorption, certain drugs, and bariatric surgery. We present a case of a 32-year-old woman from a rural area in Zanzibar who was a heavy alcohol consumer and came in with features suggestive of pellagra. Our therapeutic approach consisted of niacin 500 mg once daily and betamethasone + salicylic acid ointment twice a day until lesions resolved and showed noticeable improvement.
Sections du résumé
BACKGROUND
BACKGROUND
Pellagra is a nutritional disease resulting from a deficiency of vitamin B3 (niacin) primarily due to corn consumption, especially in developing countries, but in developed countries, it can occur secondarily as a consequence of chronic alcoholism, malabsorption, certain drugs, and bariatric surgery.
RESULTS
RESULTS
We present a case of a 32-year-old woman from a rural area in Zanzibar who was a heavy alcohol consumer and came in with features suggestive of pellagra.
CONCLUSION
CONCLUSIONS
Our therapeutic approach consisted of niacin 500 mg once daily and betamethasone + salicylic acid ointment twice a day until lesions resolved and showed noticeable improvement.
Substances chimiques
Niacin
2679MF687A
Niacinamide
25X51I8RD4
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
685-687Informations de copyright
© 2022 the International Society of Dermatology.
Références
Wan P, Moat S, Anstey A. Pellagra: a review with emphasis on photosensitivity. Br J Dermatol. 2011;164:1188-200.
Distr E. WHO ¦ Pellagra and its prevention and control in major emergencies. Available from: http://www.who.int/nutrition/publications/emergencies/WHO_NHD_00.10/en/
Hui S, Heng L, Shaodong W, Fangyu W, Zhenkai W. Pellagra affecting a patient with crohn's disease. An Bras Dermatol. 2017;92(6):879-81.
Li R, Yu K, Wang Q, Wang L, Mao J, Qian J. Pellagra secondary to medication and alcoholism: a case report and review of the literature. Nutr Clin Pract. 2016;31(6):785-9.
Viljoen M, Bipath P, Roos JL. Aetiological doctrines and prevalence of pellagra: 18th century to middle 20th century. S Afr J Sci. 2018;114:1-7.
Kipsang JK, Choge JK, Marinda PA, Khayeka-Wandabwa C. Pellagra in isoniazid preventive and antiretroviral therapy. IDCases. 2019;17:e00550. https://doi.org/10.1016/j.idcr.2019.e00550
Natsumi S, Kuroita T, Ishikawa T, Kuronuma K, Yoshioka T. Effect of niacin supplementation on nausea-like behaviour in an isoniazid-induced mouse model of pellagra. Br J Nutr. 2022;127(7):961-71.